Literature DB >> 4427221

Patterns of plasma levels of prednisolone after oral administration in man.

R Leclercq, G Copinschi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4427221     DOI： 10.1007/BF01061507

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  7 in total

1.  INFLUENCE OF VARIOUS STEROIDS ON THE SPECIFIC BINDING OF CORTISOL.

Authors:  P DEMOOR; R DECKX; O STEENO
Journal:  J Endocrinol       Date:  1963-11       Impact factor: 4.286

2.  The fluorimetric determination of corticosterone in rat adrenal tissue and plasma: effect of administering ACTH subcutaneously.

Authors:  F MONCLOA; F G PERON; R I DORFMAN
Journal:  Endocrinology       Date:  1959-10       Impact factor: 4.736

3.  Metabolism of adrenocorticosteroids in man.

Authors:  R E PETERSON
Journal:  Ann N Y Acad Sci       Date:  1959-10-14       Impact factor: 5.691

4.  Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay.

Authors:  B E Murphy
Journal:  J Clin Endocrinol Metab       Date:  1967-07       Impact factor: 5.958

5.  Radioimmunoassay for prednisolone.

Authors:  W A Colburn; R H Buller
Journal:  Steroids       Date:  1973-06       Impact factor: 2.668

6.  [Determination by competition of plasma corticol. Modification of Murphy's method].

Authors:  R Leclercq; G Copinschi; J R Franckson
Journal:  Rev Fr Etud Clin Biol       Date:  1969-10

7.  Evaluation of radio-isotope data in steroid assays based on competitive protein binding.

Authors:  R Leclercq; I B T'aejedal; S Wold
Journal:  Clin Chim Acta       Date:  1972-01       Impact factor: 3.786
  7 in total
  13 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  Plasma prednisolone levels in man following administration in plain and enteric-coated forms.

Authors:  C G Wilson; C S May; J W Paterson
Journal:  Br J Clin Pharmacol       Date:  1977-06       Impact factor: 4.335

3.  A radioimmunoassay method for prednisolone: comparison with the competitive protein binding method.

Authors:  J Chakraborty; J English; V Marks; M C Dumasia; D J Chapman
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

4.  Plasma prednisolone levels from enteric and non-enteric coated tablets estimated by an original technique.

Authors:  P J Morrison; I D Bradbrook; H J Rogers
Journal:  Br J Clin Pharmacol       Date:  1977-10       Impact factor: 4.335

Review 5.  Pharmacokinetics and bioavailability of prednisone and prednisolone in healthy volunteers and patients: a review.

Authors:  J G Gambertoglio; W J Amend; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1980-02

6.  RIV vs. CPB for prednisolone.

Authors:  W A Colburn; R H Buller
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

7.  Prednisolone absorption in coeliac disease.

Authors:  M E Pickup; F Farah; J R Lowe; J S Dixon; C O Record
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

8.  Inhibition of neutrophil migration by sera from patients with rheumatoid arthritis.

Authors:  A S Kemp; P Roberts-Thomson; S H Neoh; S Brown
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

9.  The effect of food and tablet formulation on plasma prednisolone levels following administration of enteric-coated tablets.

Authors:  D A Lee; G M Taylor; J G Walker; V H James
Journal:  Br J Clin Pharmacol       Date:  1979-05       Impact factor: 4.335

10.  [Pharmacokinetics of prednisolone in adrenal insufficiency ].

Authors:  C von Papen; G Benker; K Hackenberg; D Reinwein
Journal:  Klin Wochenschr       Date:  1982-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.